See the full story in the original article.
Read the original on CoinDesk ↗
Keywords
Open a keyword to see other news on the same topic.
Related tickers and likely impact
HYPE/USDT
▲ Likely positiveHyperliquid
Relevance: medium
| Market | Crypto |
|---|---|
| Exchange | Binance |
| Sector | Layer 1 |
| Market cap | $16.9B |
| Close on 10/28/2026 | 80.69 |
| Change that session | -0.77% |
Impact is scored by AI from the headline and may be wrong. It is not investment advice.
Related news
- Stanley Druckenmiller's first X post backs Hyperliquid venture after $23 million indirect investment
- Forget AI Stocks: 2 Cryptocurrencies to Consider Buying Instead
The article argues that the AI boom could cool, while nearly a dozen top cryptocurrencies have risen more than 100% this year. Hyperliquid (HYPE) is up 220% for the year and is estimated to control as much as 70% of the perpetual futures market on decentralized exchanges, but it remains off-limits to U.S. investors, and the Bitwise Hyperliquid ETF (BHYP) has traded since May. Zcash (ZEC) is up 136% year to date with a market cap of about $20 billion, and the Grayscale Zcash ETF (ZCSH) surpassed $1 billion in assets under management within its first 30 days. The article cautions that growth is not guaranteed: Hyperliquid needs approval to operate in the U.S., while Zcash is still about 80% below its 2016 highs.
- CFTC Chairman Michael Selig Says New Crypto Rules Are Coming Soon. Here's What Crypto Investors Need to Know.
The Clarity Act failed a procedural Senate vote on Sept. 15, but CFTC Chairman Michael Selig said the agency would pursue crypto rules under its existing powers. On Oct. 5, the CFTC issued an advance notice of proposed rulemaking, the first formal step, targeting the middle tier of exchanges that offer margin trading. Proposed measures could require proof of reserves, segregation of client money from house money, and new listing reviews examining token ownership concentration and vesting schedules. After a 60-day public comment period following Federal Register publication, a proposed rule could follow, with final rules likely in 2027. The article says Hyperliquid faces the most exposure, since its core perpetual futures business falls on the top tier that the proposal does not cover.
- Not Bitcoin. Not Ethereum. These 4 Cryptocurrencies Could Be Worth Holding for the Next 5 Years.
The article argues that Solana, NEAR, Zcash and Hyperliquid are worth considering for five-year holdings alongside Bitcoin and Ethereum. Solana held $4.4 billion in tradeable tokenized assets as of Oct. 14, its tokenized-asset holders rose 47% in 30 days, and staking yields 4.9% annually. NEAR's Intents handled $4.8 billion of swaps in 30 days, generating $8.2 million in fees used for buybacks, while a proposal to cut issuance to 1.6% over two years, down from 2.5%, has no scheduled vote. About 29% of Zcash's supply sat in shielded pools as of Oct. 14, with the next halving estimated for Nov. 23, 2028. Hyperliquid directs about 99% of trader fees to buybacks, totaling $224 million in Q3 2026, or an annualized $694 million, equal to 3.9% of its $17.8 billion market cap.
- Hyperliquid founder wants U.S. oversight of trading platforms, not his blockchain
Founder Jeff Yan told Bloomberg that U.S. regulators should oversee the firms operating trading markets on the blockchain rather than the network itself. He argued those deployers, not the underlying infrastructure, should meet regulatory requirements, which would let Wall Street firms run regulated trading businesses on Hyperliquid without the blockchain registering as an exchange. Hyperliquid remains closed to U.S. customers, but Payward, Kraken's parent, plans to offer U.S. investors derivatives using Hyperliquid's technology through a regulated exchange. His comments follow President Donald Trump's August statement that the Commodity Futures Trading Commission (CFTC) was working to bring Hyperliquid under federal regulation.
- S&P 500 options are the hottest bet on this Hyperliquid exchange
Hypercall, an options exchange built on Hyperliquid, has recorded about $640 million in notional volume since launching in June, with more than 80% coming from S&P 500 options. The platform lists daily, weekly and monthly expiries, trades around the clock and settles in USDC, with most volume concentrated in options expiring the next day. Open interest stands at about $49 million, of which $47 million is in S&P 500 options. The article says demand for blockchain access to traditional markets is growing, though volume remains small compared with Deribit, and options on SpaceX, Nvidia, Micron and SanDisk make up more than half of all trades.
Related markets
Latest news
- Alphabet Stock Drops 12%. Can Its Dividend Survive the AI Spending Boom?
Alphabet shares fell roughly 12% to around $285 after free cash flow turned negative for a second straight quarter, reaching negative $9.07 billion in the third quarter. Capital expenditure rose 114.4% year over year to $51.36 billion, above operating cash flow of $42.29 billion, mostly for AI infrastructure. The company pays a $0.22 quarterly dividend, which took about 6.9% of operating cash flow in the second quarter ($2.689 billion), and it holds $56.33 billion in cash. The gap is being filled by $28.7 billion in net proceeds from senior notes and new shares sold through an at-the-market program, while buybacks dropped to zero in the second quarter and the program was suspended. The article judges the dividend not at major risk for now, and says the next annual dividend decision is the key signal to watch.
- We're downgrading Alphabet after its rough quarter. Here's where we'd buy again
The S&P 500 and Nasdaq slipped on Thursday as post-earnings sell-offs hit technology stocks including Alphabet, ServiceNow and Fortinet. The CNBC Investing Club cut its Alphabet rating from 1 to 2 and lowered its price target to $350 from $400, but is keeping the position because of momentum in the Cloud business. The club said it would reassess if the price-to-earnings multiple falls from about 19x to the 17x-18x range and AI Mode monetization improves.
- Alphabet's Cloud Business Just Doubled. The Stock Fell 12%. Is it a Buy?
Alphabet reported third-quarter results after the close on Wednesday, and the stock fell about 10% in after-hours trading as earnings and revenue missed estimates amid heavy AI spending. Most of the earnings hit was an unrealized $8.7 billion loss on equity securities, mainly tied to its SpaceX investment, which cut EPS by $0.55, while operating income rose 30% to $40.6 billion. Google Cloud revenue more than doubled to $30.7 billion at a margin of about 36%, and its backlog reached $561 billion, up from $514 billion three months earlier. Search revenue grew 12%, down from about 17% in the second quarter, while capex of $51.4 billion pushed free cash flow to negative $9.1 billion and spending is expected to rise significantly in 2027. The author says investors are not yet convinced of the return on this spending, but that the stock's 21x forward earnings multiple after the decline may merit a closer look for long-term investors.
- Linde delivers a good quarter and puts in a fix for an overhang on the stock
Linde's third-quarter revenue rose 9.2% to $9.4 billion and adjusted EPS rose 9% to $4.59, beating LSEG consensus of $4.54 and setting quarterly records for sales, operating profit and earnings. Volume rose 2% and price/mix added 3%, while Electronics sales climbed 15% on AI infrastructure demand. Fourth-quarter guidance was slightly light and the shares fell more than 1% on the day; the author says profit-taking after the stock's recovery from a mid-September low could be another reason. The company booked a $425 million restructuring charge, about half for severance and the rest largely tied to Lincare, whose results will now sit in Other rather than the Americas. The author calls it an overall solid quarter, with a full-year outlook in line with expectations.
- Merck Lifts Outlook on a Lower Tax Rate: Rapid Earnings Reaction
Merck's third-quarter sales rose 5% to about $18.1 billion, but about $550 million of the gain came from the timing of customer purchases, and the article says sales barely grew without it. Keytruda Qlex sales reached $830 million, up from $463 million last quarter, and Winrevair sales rose 93% to $694 million, partly offsetting generic erosion of older drugs such as Januvia and Bridion, where Bridion sales fell 67%. GAAP EPS fell 12% to $2.04 and adjusted EPS fell 3% to $2.49, as spending on launches and research and higher interest expense outpaced sales, though a lower tax rate softened the hit. Merck lowered its non-GAAP tax-rate outlook to 32% to 33% from 35% to 36%, which the article says does much of the lifting in the raised full-year earnings outlook. Shares rose about 5% in Thursday morning trading, and the article flags fourth-quarter sales and Qlex's share of Keytruda sales, now nearly 10%, as items to watch.
- 70% of UPS Packages Will Be Handled by Machines This Holiday Season
UPS expects nearly 70% of packages during the holiday peak to pass through automated sorting inside its buildings, CEO Carol Tomé said on the Oct. 27, 2026 third-quarter call, while drivers still deliver every box. The company is shifting to a sensing network based on RFID tags, which are active at 315 customer locations and are expected to reach 6 million packages a day in 2027, replacing manual scans. A little over 100 U.S. customers account for about 80% of the peak, and fourth-quarter daily volume is expected to fall 1.3% year over year as UPS cut volume from Amazon. U.S. Domestic daily volume fell to 15.621 million pieces from 16.150 million, yet adjusted margin rose to 7.0% from 6.4%, even as cost per piece rose 5.5%. The article notes that dividend coverage is tight, with free cash flow guidance of about $6.1 billion against planned dividends of around $5.4 billion.
Get the briefing on Telegram or Zalo
Join the Upside Telegram channel or Zalo group for the Vietnam stocks and gold briefing at 8:00 and 19:00 (Vietnam time) on trading days, plus a weekly wrap on Saturday morning.